| Market Capitalization (Millions $) |
1,057 |
| Shares
Outstanding (Millions) |
40 |
| Employees |
829 |
| Revenues (TTM) (Millions $) |
746 |
| Net Income (TTM) (Millions $) |
15 |
| Cash Flow (TTM) (Millions $) |
-156 |
| Capital Exp. (TTM) (Millions $) |
7 |
Business Description
Pacira Biosciences Inc. is a specialty pharmaceutical company that focuses on developing and commercializing innovative drug therapies that enhance patient outcomes. The company's portfolio includes best-in-class regional anesthesia and analgesia products, as well as long-acting local anesthetic formulations for postoperative pain management.
The company was founded in 2006 as Pacira Pharmaceuticals, Inc. and is headquartered in Parsippany, New Jersey. It has grown rapidly in recent years, with a strong track record of clinical research and development, as well as a commitment to sustainability and social responsibility.
One of Pacira's flagship products is Exparel, a long-acting, liposome-based local anesthetic that provides up to 72 hours of pain relief following surgery. Exparel has been approved by the FDA for a wide variety of surgical procedures, and is considered a safe and effective alternative to traditional opioid-based pain management strategies.
Pacira's other products include DepoCyt(e), a chemotherapy drug for the treatment of lymphomatous meningitis, and iovera, a non-opioid, non-invasive pain management system that uses cold therapy to block nerve signals and provide pain relief.
In addition to its pharmaceutical products, Pacira is also committed to sustainability and social responsibility. The company has implemented several initiatives aimed at reducing its environmental impact, including a zero-waste program and efforts to minimize energy and water usage. It also supports a range of philanthropic causes, including organizations focused on cancer research and patient advocacy.
Overall, Pacira Biosciences Inc. is a cutting-edge pharmaceutical company that is pioneering innovative drug therapies for pain management and making significant progress in achieving sustainable and socially responsible business practices.
Company Address: 2000 Sierra Point Parkway, Suite 900 Brisbane 94005 CA
Company Phone Number: 242-8052 Stock Exchange / Ticker: NASDAQ PCRX
|
6.02% 
191.2 %